MWOE:XETRA:XETRA-Amundi MSCI World UCITS ETF DR USD Inc EUR (EUR)

ETF | Others |

Last Closing

USD 13.412

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+1.20 (+2.33%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.39 (+2.31%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.72 (+2.67%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.64 (+2.29%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.53 (+2.15%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.46 (+1.75%)

USD 102.09B
JARI:XETRA Amundi Index Solutions - Amund..

+0.57 (+1.26%)

USD 101.20B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+1.22 (+2.39%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.56 (+0.54%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.28 (+0.38%)

USD 80.38B

ETFs Containing MWOE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.40% 82% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.40% 81% B- 81% B-
Trailing 12 Months  
Capital Gain 24.51% 82% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.51% 81% B- 81% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.94% 69% C- 68% D+
Dividend Return 10.94% 68% D+ 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.29% 57% F 65% D
Risk Adjusted Return 96.84% 88% B+ 90% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike